Leaflet DUCRESSA 1mg / 5mg / ml ophthalmic drops solution


Indicated for: bacterial infections

Substance: dexamethasone + levofloxacin (glucocorticoid + fluoroquinolone antibiotic)

ATC: S01CA01 (Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination)

Dexamethasone + levofloxacin is a combination medication primarily used for the treatment of eye infections involving inflammation and bacterial infection. This combination is commonly available as eye drops and combines a corticosteroid with an antibiotic:

- Dexamethasone is a corticosteroid that reduces inflammation, swelling, redness, and discomfort associated with eye infections.
- Levofloxacin is an antibiotic from the fluoroquinolone class that works by killing the bacteria responsible for the infection.

This combination is indicated for the treatment of bacterial eye infections, such as bacterial conjunctivitis, keratitis, or other inflammatory eye conditions associated with bacterial infections.

Side effects may include a burning or stinging sensation in the eye, temporary blurred vision, dry eyes, or, in rare cases, allergic reactions. Prolonged use of corticosteroids may increase the risk of secondary infections, glaucoma, or cataracts. It is important to use the medication as prescribed by a doctor and not discontinue it without medical advice.

General data about DUCRESSA 1mg / 5mg / ml

  • Substance: dexamethasone + levofloxacin
  • Date of last drug list: 01-05-2026
  • Commercial code: W67119001
  • Concentration: 1mg / 5mg / ml
  • Pharmaceutical form: ophthalmic drops solution
  • Quantity: 1
  • Product type: original
  • Price: 41.23 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: SANTEN OY - FINLANDA
  • Holder: SANTEN OY - FINLANDA
  • Number: 13368/2020/01
  • Shelf life: 2 years-after the first opening of the bottle;after the first opening -28 days